Characteristics of lipid profile and effectiveness of management of dyslipidaemia in patients with acute coronary syndromes – Data from the TERCET registry with 19,287 patients-Reference-Cited by-同舟云学术

Characteristics of lipid profile and effectiveness of management of dyslipidaemia in patients with acute coronary syndromes – Data from the TERCET registry with 19,287 patients

Published:2019-01 Issue: Volume:139 Page:460-466
ISSN:1043-6618
Container-title:Pharmacological Research
language:en
Short-container-title:Pharmacological Research

Author:

Dyrbus Krzysztof^ORCID,Gasior Mariusz,Desperak Piotr,Nowak Jolanta,Osadnik Tadeusz,Banach Maciej^ORCID

Funder

3rd Chair and Department of Cardiology, Medical University of Silesia in Katowice, School of Medicine with the Division of Dentistry in Zabrze, Silesian Center for Heart Diseases, Zabrze, Poland

Publisher

Elsevier BV

Subject

Pharmacology

Reference41 articles.

1. The World Health Report;WHO, World Health Organization,2008

2. European Health for All Database;World Health Organization Regional Office for Europe (HFA-DB),2014

3. Incidence, treatment, in-hospital mortality and one-year outcomes of acute myocardial infarction in Poland in 2009-2012--nationwide AMI-PL database;Gierlotka;Kardiol. Pol.,2015

4. Is statin-modified reduction in lipids the most important preventive therapy for cardiovascular disease? A pro/con debate;Hobbs;BMC Med.,2016

5. Clinical implications of the IMPROVE-IT trial in the light of current and future lipid-lowering treatment options;Serban;Expert Opin. Pharmacother.,2016

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intensive Statin Therapy Versus Upfront Combination Therapy of Statin and Ezetimibe in Patients With Acute Coronary Syndrome: A Propensity Score Matching Analysis Based on the PL‐ACS Data;Journal of the American Heart Association;2023-09-19

2. Appropriateness of Dyslipidemia Management Strategies in Post-Acute Coronary Syndrome: A 2023 Update;Metabolites;2023-08-04

3. Regional differences in physicians’ behavior and factors influencing the intensity of PCSK9 inhibitor therapy with alirocumab: a subanalysis of the ODYSSEY APPRISE study;Frontiers in Cardiovascular Medicine;2023-06-19

4. Uncovering Predictors of Lipid Goal Attainment in Type 2 Diabetes Outpatients Using Logic Learning Machine: Insights from the AMD Annals and AMD Artificial Intelligence Study Group;Journal of Clinical Medicine;2023-06-16

5. Lipid treatment status and goal attainment among patients with premature acute coronary syndrome in Israel;Journal of Clinical Lipidology;2023-05